Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders
暂无分享,去创建一个
R. Kream | G. Stefano | R. Ptáček | J. Raboch | N. Pilonis | J Raboch | R M Kream | M. Vňuková | G B Stefano | N Pilonis | R Ptacek | M Vnukova | G. B. Stefano | N. Pilonis
[1] A. Kraneveld,et al. Exploring Braak’s Hypothesis of Parkinson’s Disease , 2017, Front. Neurol..
[2] Avijit Ray,et al. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis , 2015, Immunology.
[3] A. Jačan,et al. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication , 2016, Brain, Behavior, and Immunity.
[4] D. Devos,et al. Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.
[5] J. Cryan,et al. Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system. , 2016, Developmental biology.
[6] L. Bodea,et al. Neurodegeneration by Activation of the Microglial Complement–Phagosome Pathway , 2014, The Journal of Neuroscience.
[7] R. Kream,et al. Psychiatric Disorders Involving Mitochondrial Processes , 2015 .
[8] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[9] R. Kream,et al. Antibiotics May Trigger Mitochondrial Dysfunction Inducing Psychiatric Disorders , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[10] E. Noble,et al. Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment , 2017, Front. Behav. Neurosci..
[11] Satinder K. Singh,et al. Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters. , 2015, Methods in enzymology.
[12] R. Kream,et al. Mitochondria, Microbiome and Their Potential Psychiatric Modulation , 2015 .
[13] Gregor Bieri,et al. Internalization, axonal transport and release of fibrillar forms of alpha-synuclein , 2018, Neurobiology of Disease.
[14] P. Conti,et al. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. , 2015, Clinical therapeutics.
[15] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[16] H. Savelkoul,et al. Immune dysregulation in autism spectrum disorder , 2013, European Journal of Pediatrics.
[17] B. Main,et al. Microbial Immuno-Communication in Neurodegenerative Diseases , 2017, Front. Neurosci..
[18] H. Braak,et al. Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff , 2017, Journal of Parkinson's disease.
[19] J. Eisen,et al. The enteric nervous system promotes intestinal health by constraining microbiota composition , 2017, PLoS biology.
[20] W. D. de Vos,et al. Homeostasis of the gut barrier and potential biomarkers , 2016, American journal of physiology. Gastrointestinal and liver physiology.
[21] T. Dinan,et al. A gut (microbiome) feeling about the brain , 2016, Current opinion in gastroenterology.
[22] H. Forssberg,et al. Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.
[23] J. Foster,et al. Psychobiotics and the gut–brain axis: in the pursuit of happiness , 2015, Neuropsychiatric disease and treatment.
[24] T. Dinan,et al. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. , 2014, Advances in experimental medicine and biology.
[25] J. Turner,et al. Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. , 2009, Gastroenterology.
[26] G. Boeckxstaens,et al. Neuron-macrophage crosstalk in the intestine: a “microglia” perspective , 2015, Front. Cell. Neurosci..
[27] Sylvia Daunert,et al. Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis , 2017, Journal of cellular physiology.
[28] J. Quevedo,et al. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. , 2017, Journal of affective disorders.
[29] S. Thompson,et al. An excitatory synapse hypothesis of depression , 2015, Trends in Neurosciences.
[30] Luis Pedro Coelho,et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.
[31] Richard J Smeyne,et al. Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior , 2016, Cell host & microbe.
[32] P. Sternberg,et al. A comparison of experience-dependent locomotory behaviors and biogenic amine neurons in nematode relatives of Caenorhabditis elegans , 2010, BMC Neuroscience.
[33] Jeffrey H. Kordower,et al. Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.
[34] H. Malkki. Parkinson disease: Could gut microbiota influence severity of Parkinson disease? , 2017, Nature Reviews Neurology.
[35] G. Stefano,et al. Dopaminergic agents: influence on serotonin in the molluscan nervous system. , 1976, Science.
[36] Wenjie Xie,et al. Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease , 2001, The Journal of Neuroscience.
[37] V. Pachnis,et al. The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System , 2016, Gastroenterology.
[38] R. Dobbs,et al. Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .
[39] T. Borody,et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.
[40] T. Dinan,et al. Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome , 2017, Neuropsychopharmacology.
[41] M. Muqit,et al. PINK1 and Parkin: emerging themes in mitochondrial homeostasis. , 2017, Current opinion in cell biology.
[42] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[43] Daniel J. Chandler,et al. Noradrenergic Modulation of Cognition in Health and Disease , 2017, Neural plasticity.
[44] M. Thangaraju,et al. Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine , 2016, The Journal of Immunology.
[45] J. Kong,et al. Transcutaneous Vagus Nerve Stimulation: A Promising Method for Treatment of Autism Spectrum Disorders , 2017, Front. Neurosci..
[46] D. Haller,et al. Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer , 2018, Front. Immunol..
[47] Rustem F. Ismagilov,et al. Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015, Cell.
[48] J. Hoffman,et al. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.
[49] N. Van Rooijen,et al. Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease , 2010, Journal of neurochemistry.
[50] Eric Gouaux,et al. Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.
[51] G. Stefano,et al. Microglia in invertebrate ganglia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[52] T. Dinan,et al. Collective unconscious: how gut microbes shape human behavior. , 2015, Journal of psychiatric research.
[53] E. Nam,et al. Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRI , 2017, Neuromodulation : journal of the International Neuromodulation Society.
[54] V. Napolioni,et al. Urinary p-cresol in autism spectrum disorder. , 2013, Neurotoxicology and teratology.
[55] F. Özoğul,et al. Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method , 2004 .
[56] E. Tobe. Mitochondrial dysfunction, oxidative stress, and major depressive disorder , 2013, Neuropsychiatric disease and treatment.
[57] Sara Omenetti,et al. The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome , 2015, Front. Immunol..
[58] K. Helke,et al. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease , 2017, Brain Stimulation.
[59] H. Chuang,et al. Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice , 2016, Behavioural Brain Research.
[60] T. Dinan,et al. The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus , 2018, European Neuropsychopharmacology.
[61] I. Korona-Głowniak,et al. The Association of Chronic Hepatitis C with Respiratory Microbiota Disturbance on the Basis of Decreased Haemophilus Spp. Colonization , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[62] C. Conway,et al. Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: A case series , 2017, Brain Stimulation.
[63] G. Fricchione,et al. The immune-neuro-link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry , 1994, Progress in Neurobiology.
[64] N. Spencer,et al. The Diverse Metabolic Roles of Peripheral Serotonin. , 2017, Endocrinology.
[65] P. Deyn,et al. Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story , 2017, Neurochemistry International.
[66] Dean P. Jones,et al. Redox dynamics of manganese as a mitochondrial life-death switch. , 2017, Biochemical and biophysical research communications.
[67] K. Dujardin,et al. Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies. , 2017, Journal of psychosomatic research.
[68] R. Kream,et al. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). , 2007, International journal of molecular medicine.
[69] C. Duyckaerts,et al. The second brain and Parkinson’s disease , 2009, The European journal of neuroscience.
[70] P. Trosvik,et al. Linking Spatial Structure and Community-Level Biotic Interactions through Cooccurrence and Time Series Modeling of the Human Intestinal Microbiota , 2017, mSystems.
[71] S. Finegold,et al. Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.
[72] R. Kream,et al. Mitochondrial DNA heteroplasmy in human health and disease , 2016, Biomedical reports.
[73] R. Kream,et al. Dopamine, Morphine, and Nitric Oxide: An Evolutionary Signaling Triad , 2009, CNS neuroscience & therapeutics.
[74] B. Bonaz,et al. Brain-gut-microbiota axis in Parkinson's disease. , 2015, World journal of gastroenterology.
[75] P. Blain,et al. Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.
[76] T. Weir,et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.
[77] E. Pekkonen,et al. More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota , 2017, European journal of neurology.
[78] R. Dobbs,et al. Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. , 1999, Acta neurologica Scandinavica.
[79] R. Milev,et al. The effects of probiotics on depressive symptoms in humans: a systematic review , 2017, Annals of General Psychiatry.
[80] J. Galligan,et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. , 2012, Gastroenterology.
[81] G. Rizzo,et al. Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[82] Kevin D Young,et al. Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan. , 2013, Microbiology.
[83] Helen Tremlett,et al. The gut microbiome in human neurological disease: A review , 2017, Annals of neurology.
[84] R. Blakely,et al. A dialogue between the immune system and brain, spoken in the language of serotonin. , 2013, ACS chemical neuroscience.
[85] A. Ivanov. Structure and regulation of intestinal epithelial tight junctions: current concepts and unanswered questions. , 2012, Advances in experimental medicine and biology.
[86] H. Braak,et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.
[87] V. A. Shishov,et al. Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12 , 2009, Applied Biochemistry and Microbiology.
[88] R. Milev,et al. Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review , 2017, Annals of General Psychiatry.
[89] R. Kream,et al. Evolutionary Perspective on Microglial/Neuronal Coupling with Special Relevance to Psychiatric Illnesses , 2015 .
[90] F. Cardarelli,et al. Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin‐binding dynamics , 2012, Clinical genetics.
[91] E. Pennacchietti,et al. Glutamate decarboxylase‐dependent acid resistance in orally acquired bacteria: function, distribution and biomedical implications of the gadBC operon , 2012, Molecular microbiology.
[92] J. Sonnenburg,et al. Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] Alan Frazer,et al. Vagal Nerve Stimulation for Treatment-Resistant Depression , 2017, Neurotherapeutics.
[94] T. Dinan,et al. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. , 2016, Journal of psychiatric research.
[95] M. Gerstein,et al. FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.
[96] J. Tack,et al. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders , 2007 .
[97] S. Mazmanian,et al. The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. , 2017, Immunity.
[98] P. Brundin,et al. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis , 2015, Neurobiology of Disease.
[99] Metazoan innovation: from aromatic amino acids to extracellular signaling , 2013, Amino Acids.
[100] V. V. Roshchina,et al. Evolutionary Considerations of Neurotransmitters in Microbial, Plant, and Animal Cells , 2010 .
[101] H. Krum,et al. Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction , 2014, Autonomic Neuroscience.
[102] J. Beatty,et al. Genetic analysis of a bacterial genetic exchange element: the gene transfer agent of Rhodobacter capsulatus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[103] J. Lewis,et al. Diet, the human gut microbiota, and IBD. , 2013, Anaerobe.
[104] K. Fassbender,et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.
[105] M. Rugge,et al. Antibiotic‐induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice , 2017, British journal of pharmacology.
[106] M. Andresen,et al. Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract. , 2017, American journal of physiology. Heart and circulatory physiology.
[107] J Licinio,et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism , 2016, Molecular Psychiatry.
[108] T. R. Licht,et al. Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class , 2015, PloS one.
[109] B. Stecher,et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis , 2017, Nature Communications.
[110] T. Dinan,et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.